A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 16, 2010

Primary Completion Date

April 29, 2011

Study Completion Date

April 29, 2011

Conditions
Macular Degeneration
Interventions
DRUG

Pazopanib

Pazopanib tablet

Trial Locations (7)

33880

GSK Investigational Site, Winter Haven

46290

GSK Investigational Site, Indianapolis

49525

GSK Investigational Site, Grand Rapids

78705

GSK Investigational Site, Austin

90211

GSK Investigational Site, Beverly Hills

95819

GSK Investigational Site, Sacramento

95841

GSK Investigational Site, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY